Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab as First-Line Therapy for B-Cell Lymphomas: A Phase I Study

BACKGROUND: We conducted an investigator-initiated, phase I trial of vincristine sulfate liposomal injection (VSLI) in combination with bendamustine and rituximab (BR) for indolent B-cell (BCL) or mantle cell lymphoma. METHODS: Participants received 6 cycles of standard BR with VSLI at patient-speci...

Descripción completa

Detalles Bibliográficos
Autores principales: Ollila, Thomas, Butera, James, Egan, Pamela, Reagan, John, Thomas, Anthony, Yakirevich, Inna, MacKinnon, Kelsey, Margolis, Jeannine, McMahon, Jessica, Rosati, Valerie, Olszewski, Adam J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255974/
https://www.ncbi.nlm.nih.gov/pubmed/35641232
http://dx.doi.org/10.1093/oncolo/oyab079

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9255974/
https://www.ncbi.nlm.nih.gov/pubmed/35641232
http://dx.doi.org/10.1093/oncolo/oyab079

Ejemplares similares